Status:
COMPLETED
Topical Local Anaesthesia and Cooling During Capsaicin 8% Patch Application
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Astellas Pharma GmbH
Conditions:
Pain
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the study is to demonstrate superiority of a continuous cooling of the skin over topical EMLA or placebo in reducing the burning pain during the application of capsaicin 8% patch ("Qutenza"). ...
Detailed Description
According to literature, one of the most common adverse events of capsaicin 8% patch is a burning pain and a reversible erythema at the application site. In general it is recommended to apply a topica...
Eligibility Criteria
Inclusion
- healthy volunteers 18 ore more years old
Exclusion
- dermatologic or neurologic injuries on both thighs
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01523951
Start Date
January 1 2012
End Date
March 1 2012
Last Update
March 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Spec. Anesthesia and Pain Therapy
Vienna, Vienna, Austria, 1090